<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Summit Therapeutics Inc (SMMT)</title>
    <description>Latest news, press releases, and SEC filings for Summit Therapeutics Inc (SMMT)</description>
    <link>https://caymanjournal.com/stock/SMMT</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 21:33:46 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/SMMT/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>PRE 14A — Summit Therapeutics Inc.</title>
      <description># 🧾 What This Document Is
This is a **PRELIMINARY proxy statement (PRE 14A)** for Summit Therapeutics. It&apos;s the &quot;advance notice&quot; and agenda for the company&apos;s upcoming virtual annual shareholder meeting. Its purpose is to give shareholders the information they need to vote on important company matte</description>
      <link>https://caymanjournal.com/stock/SMMT/sec-filing/0001599298-26-000021</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/SMMT/sec-filing/0001599298-26-000021</guid>
      <pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>